Dapagliflozin vs Rosuvastatin

Dapagliflozin vs Rosuvastatin: Overview

This comparison examines the pharmacological differences between Dapagliflozin and Rosuvastatin.

Mechanism of Action

Dapagliflozin: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

Rosuvastatin: Competitive inhibitor of HMG-CoA reductase.

Pharmacokinetics

Half-life: Dapagliflozin — 12.9 hours; Rosuvastatin — 19 hours.

Chemical Properties

Molecular Formula: Dapagliflozin — C21H25ClO6; Rosuvastatin — C22H28FN3O6S.

Molecular Weight: Dapagliflozin — 408.8730 g/mol; Rosuvastatin — 481.5390 g/mol.

Type: Dapagliflozin — Small molecule; Rosuvastatin — Small molecule.